170 related articles for article (PubMed ID: 37872497)
1. Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits).
Bejerot S; Eklund D; Hesser H; Hietala MA; Kariis T; Lange N; Lebedev A; Montgomery S; Nordenskjöld A; Petrovic P; Söderbergh A; Thunberg P; Wikström S; Humble MB;
BMC Psychiatry; 2023 Oct; 23(1):771. PubMed ID: 37872497
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis.
Foley ÉM; Griffiths SL; Murray A; Rogers J; Corsi-Zuelli F; Hickinbotham H; Warwick E; Wilson M; Kaser M; Murray GK; Deakin B; Jadon D; Suckling J; Barnes NM; Upthegrove R; Khandaker GM;
BMJ Open; 2023 Mar; 13(3):e067944. PubMed ID: 36963796
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
Lennox B; Yeeles K; Jones PB; Zandi M; Joyce E; Yu LM; Tomei G; Pollard R; Vincent SA; Shimazaki M; Cairns I; Dowling F; Kabir T; Barnes TRE; Lingford Hughes A; Hosseini AA; Harrower T; Buckley C; Coles A
Trials; 2019 Jun; 20(1):331. PubMed ID: 31174586
[TBL] [Abstract][Full Text] [Related]
4. Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
Nasib LG; Sommer IE; Winter-van Rossum I; de Vries J; Gangadin SS; Oomen PP; Judge G; Blom RE; Luykx JJ; van Beveren NJM; Veen ND; Kroken RA; Johnsen EL
Trials; 2020 Jun; 21(1):492. PubMed ID: 32513294
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.
Whicher CA; Price HC; Phiri P; Rathod S; Barnard-Kelly K; Reidy C; Thorne K; Asher C; Peveler R; McCarthy J; Holt RIG
Trials; 2019 Nov; 20(1):633. PubMed ID: 31747930
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
Gaughran F; Stringer D; Berk M; Smith S; Taylor D; Whiskey E; Landau S; Murray R; McGuire P; Gardner-Sood P; Wojewodka G; Ciufolini S; Jordan H; Clarke J; Allen L; Krivoy A; Stubbs B; Lowe P; Arbuthnott M; Rathod S; Boardman A; Firdosi M; McGrath JJ
Trials; 2020 Jan; 21(1):14. PubMed ID: 31907006
[TBL] [Abstract][Full Text] [Related]
9. Antiglucocorticoid and related treatments for psychosis.
Garner B; Phillips LJ; Bendall S; Hetrick SE
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006995. PubMed ID: 26725721
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu A; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Romeo R; Gray R
Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu AV; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Gray R;
Lancet Psychiatry; 2018 Jul; 5(7):553-563. PubMed ID: 29880238
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Tahara M; Oeda T; Okada K; Kiriyama T; Ochi K; Maruyama H; Fukaura H; Nomura K; Shimizu Y; Mori M; Nakashima I; Misu T; Umemura A; Yamamoto K; Sawada H
Lancet Neurol; 2020 Apr; 19(4):298-306. PubMed ID: 32199095
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.
Jones A; Muller P; Dore CJ; Ikeji F; Caverly E; Chowdhury K; Isenberg DA; Gordon C; Ehrenstein MR
BMJ Open; 2019 Dec; 9(12):e032569. PubMed ID: 31848169
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
17. Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation.
Khandaker GM; Oltean BP; Kaser M; Dibben CRM; Ramana R; Jadon DR; Dantzer R; Coles AJ; Lewis G; Jones PB
BMJ Open; 2018 Sep; 8(9):e025333. PubMed ID: 30244217
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
